Author Information
Tomer Ziv-Baran is a prominent researcher affiliated with the Department of Epidemiology and Preventive Medicine at the School of Public Health, Sackler Faculty of Medicine, Tel Aviv University, located in Tel Aviv, Israel. His work is deeply rooted in epidemiological studies, and he has contributed significantly to the understanding of various medical and health-related issues through his research.Research Contributions
Tomer Ziv-Baran's research contributions are vast and varied, spanning across different areas of epidemiology and medicine. In recent years, he has published papers on diverse topics such as the prognosis of Primary Sclerosing Cholangitis, immune responses in HIV patients following COVID-19 vaccination, and the impacts of infliximab infusion timing. His work also includes studies on the efficacy of COVID-19 vaccines in patients with chronic lymphocytic leukemia and solid malignancies, the role of social media in supporting patients with inflammatory bowel diseases, and the importance of medical expertise in emergency department operations. His research is characterized by its focus on critical health issues and its application to improving clinical practices and patient outcomes.Aliases
Tomer Ziv-Baran is known by several aliases in academic circles, including T. Ziv-baran, T. Ziv\u2010baran, T. Ziv-baran, and Tomer Ziv\u2010baran. These variations may appear in different publications and databases.Publication and Citation Metrics
| Metric |
Value |
| Total Citation Count |
2941 |
| H-index |
23 |
| Total Paper Count |
197 |
